View the MORIHEPAMIN registration information details.
Back to drug list
ItemsDrug Registration information
ID53
No53
Brand NameMORIHEPAMIN
IngredientsEACH 200 ML CONTAINS: L-ISOLEUCINE 1.840 G, L-LEUCINE 1.890 G, L-LYSINE ACETATE 0.790 G, L-METHIONINE 0.088 G, L-PHENYLALANINE 0.060 G, L-THREONINE 0.428 G, L-TRYPTOPHAN 0.140 G, L-VALINE 1.780 G, L-ALANINE 1.680 G, L-ARGININE 3.074 G, L-ASPARTIC ACID 0.040 G, L-HISTI9DINE 0.620 G, L-PROLINE 1.060 G, L-SERINE 0.520 G, L-TYROSINE 0.080 G, GLYCINE 1.080 G
Dosage FormSOLUTION FOR INFUSION
Primary PackagingPLASTIC BAG
Storage
Shelf Life3 YEARS
Pack Size200 ML/BAG
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR SUPPORTIVE TREATMENT FOR HEPATIC ENCEPHALOPATHY SYNDROME IN PATIENTS WITH CHRONIC LIVER DISEASE
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionCLEAR AND COLORLESS AQUEOUS SOLUTION FOR INJECTION
Note
License OwnerAI KEN PHARMA CO., LTD
ManufacturerAY PHARMACEUTICALS CO.,LTD. SHIMIZU PLANT
CountryJAPAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 I 5331/22
FDD Registration Date01/12/2022
Expiry Date30/11/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA